The FDA has assigned<unk>  to pregnancy category C. Animal studies have reported incidences of fetal mortality and growth deficit.<unk>  has not been tested during human pregnancy, and should be administered with caution. In addition, it has not been determined whether the excretion of<unk>  occurs in breast milk.
Lacosamide
Galantamine
Tianeptine
Benzonatate
Gliquidone
Mannitol
Zonisamide
Acotiamide